NASDAQ:BSGM BioSig Technologies (BSGM) Stock Price, News & Analysis $0.41 -0.04 (-8.89%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.35▼$0.4550-Day Range$0.33▼$2.4052-Week Range$0.20▼$10.00Volume46,667 shsAverage Volume615,698 shsMarket Capitalization$5.82 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get BioSig Technologies alerts: Email Address Ad Porter & CompanyKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but they do not care.I have uncovered a bombshell that changes everything… and threatens everything. About BioSig Technologies Stock (NASDAQ:BSGM)BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.Read More BSGM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BSGM Stock News HeadlinesJuly 25 at 6:05 PM | uk.finance.yahoo.comEVs are still 'in a tough spot right now': Auto expertJuly 25 at 1:57 PM | globenewswire.comBioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024July 26, 2024 | Monument Traders Alliance (Ad)NEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...June 10, 2024 | globenewswire.comBioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting OfficerMay 30, 2024 | globenewswire.comBioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesMay 21, 2024 | globenewswire.comBioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to ShareholdersMay 3, 2024 | globenewswire.comBioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 IndependentApril 30, 2024 | marketwatch.comBioSig Technologies Appoints Amato as CEO Following Engagement With Consulting FirmJuly 26, 2024 | Monument Traders Alliance (Ad)NEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...April 30, 2024 | globenewswire.comBioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective ImmediatelyApril 18, 2024 | thestreet.comBioSig Technologies Inc.April 10, 2024 | msn.comAptevo Therapeutics, TRACON Pharmaceuticals, Biosig Technologies among healthcare moversApril 8, 2024 | msn.comU.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.03%April 4, 2024 | finance.yahoo.comBioSig Engages Consulting Firm for Business Model StrategiesApril 4, 2024 | globenewswire.comBioSig Engages Consulting Firm for Business Model StrategiesFebruary 29, 2024 | investing.comBiosig Technologies Inc (BSGM)February 23, 2024 | msn.comU.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.13%February 22, 2024 | benzinga.comBioSig Technologies Stock (NASDAQ:BSGM) Earnings Dates and Earning CallsSee More Headlines Receive BSGM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/20/2024Today7/26/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:BSGM CUSIPN/A CIK1530766 Webwww.biosig.com Phone(230) 409-5444FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,040,000.00 Net MarginsN/A Pretax Margin-91,566.66% Return on EquityN/A Return on Assets-951.37% Debt Debt-to-Equity RatioN/A Current Ratio0.14 Quick Ratio0.14 Sales & Book Value Annual Sales$20,000.00 Price / Sales290.90 Cash FlowN/A Price / Cash FlowN/A Book Value($0.33) per share Price / Book-1.24Miscellaneous Outstanding Shares14,190,000Free Float12,867,000Market Cap$5.82 million OptionableOptionable Beta0.65 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report Key ExecutivesMr. Frederick D. Hrkac (Age 58)President, Principal Executive Officer, Executive VP & Director Mr. Anthony Amato (Age 56)CEO & Director Dr. Budimir S. Drakulic Ph.D. (Age 74)Chief Scientist Comp: $169.64kMr. Andrew Gornell BallouVice President of Investor RelationsKey CompetitorsPixie Dust TechnologiesNASDAQ:PXDTNeurAxisNASDAQ:NRXSStar EquityNASDAQ:STRRQT ImagingNASDAQ:QTINexalin TechnologyNASDAQ:NXLView All Competitors BSGM Stock Analysis - Frequently Asked Questions How have BSGM shares performed this year? BioSig Technologies' stock was trading at $4.75 at the beginning of 2024. Since then, BSGM shares have decreased by 91.4% and is now trading at $0.41. View the best growth stocks for 2024 here. How were BioSig Technologies' earnings last quarter? BioSig Technologies, Inc. (NASDAQ:BSGM) released its quarterly earnings results on Monday, May, 20th. The company reported ($0.36) earnings per share for the quarter. The company had revenue of $0.01 million for the quarter. When did BioSig Technologies' stock split? Shares of BioSig Technologies reverse split before market open on Friday, February 2nd 2024. The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of BioSig Technologies? Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of BioSig Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN) and Dynavax Technologies (DVAX). This page (NASDAQ:BSGM) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioSig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioSig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
